Abstract P264: Circulating and Dietary Magnesium and Risk of Cardiovascular Disease: A Systematic Review and Meta-analysis of Prospective Studies

Circulation ◽  
2013 ◽  
Vol 127 (suppl_12) ◽  
Author(s):  
Liana C Del Gobbo ◽  
Fumiaki Imamura ◽  
Jason H Wu ◽  
Marcia C de Oliviera Otto ◽  
Stephanie E Chiuve ◽  
...  
Keyword(s):  
Systematic Review ◽  
Cardiovascular Disease ◽  
Prospective Studies ◽  
Lower Risk ◽  
Meta Analysis ◽  
Grey Literature ◽  
Statistical Testing ◽  
Inverse Association ◽  
Dietary Magnesium ◽  
Non Linear

Background: Clinical hypomagnesemia and experimental dietary magnesium (Mg) restriction diets are associated with cardiac arrhythmias. Relationships between circulating or dietary Mg at usual concentrations or intakes and risk of cardiovascular disease (CVD), including fatal coronary heart disease (CHD), are not well established. Objective: We performed a systematic review and meta-analysis to summarize all available evidence from prospective studies on the associations between circulating and dietary Mg intake with incidence of total CVD, total CHD, and fatal CHD. Methods: Multiple literature databases and grey literature were systematically searched without language restriction from the earliest online index date to May 2012 for all prospective cohort or nested case-control studies examining the association of circulating or dietary Mg intake with incident total CVD, total CHD and fatal CHD. Two investigators evaluated full text articles for inclusion/exclusion and extracted data, independently and in duplicate. Linear dose-response relationships were assessed using generalized least-squares trend estimation, with pooled RR’s determined using fixed-effects or random-effects in the presence of heterogeneity (I2>30%). Potential non-linear associations were assessed using restricted cubic splines. Prespecified sources of heterogeneity were explored using meta-regression. Publication bias was assessed using formal statistical testing and visual inspection of funnel plots. Results: Of 2,303 abstracts reviewed, 16 studies met eligibility criteria, comprising 761,742 individuals and 11,995 total CVD, 7,534 total CHD, and 2,686 fatal CHD events. In pooled analyses, circulating Mg (per 0.2mmol/L increment) was associated with a 30% lower risk of total CVD (RR=0.70, 95% CI=0.56-0.88; I2=50%) and trends towards lower risk of total CHD (RR=0.83, 95% CI=0.75-1.05; I2=47%) and fatal CHD (RR=0.61, 95% CI=0.37-1.00; I2=80%). Dietary Mg (per 200mg/day increment) was not significantly associated with total CVD (RR=0.89, 95% CI=0.75-1.05; I2=67%), but was associated with a 22% lower risk of total CHD (RR=0.78, 95% CI=0.67-0.92; I2=44%). The association between dietary Mg and fatal CHD was non-linear (p<0.0001), with an inverse association observed up to a threshold of ~250 mg/day (compared to lower intakes, RR=0.73, 95% CI=0.62-0.86). Funnel plot asymmetry was evident for the association between circulating Mg and total CVD, explained by heterogeneity due to stronger associations (p=0.02) in studies including participants with prevalent CVD at baseline and evaluating fatal CHD. Conclusions: Circulating Mg and dietary Mg intake are associated with lower risk of CVD, in particular fatal CHD. These findings support the need for randomized clinical trials and experimental studies to evaluate the possible role of Mg in the prevention of CVD and CHD death.

scholarly journals Nut consumption and incidence of cardiovascular diseases and cardiovascular disease mortality: a meta-analysis of prospective cohort studies

2019 ◽  
Vol 77 (10) ◽  
pp. 691-709 ◽  
Author(s):  
Nerea Becerra-Tomás ◽  
Indira Paz-Graniel ◽  
Cyril W.C. Kendall ◽  
Hana Kahleova ◽  
Dario Rahelić ◽  
...  
Keyword(s):  
Systematic Review ◽  
Cardiovascular Disease ◽  
Prospective Studies ◽  
Data Extraction ◽  
Meta Analysis ◽  
Nutrition Therapy ◽  
Grade System ◽  
Pool Data ◽  
Inverse Association ◽  
Stroke Incidence

Abstract Context Previous meta-analyses evaluating the association between nut consumption and the risk of cardiovascular disease (CVD) had substantial methodological limitations and lacked recently published large prospective studies; hence, making an updated meta-analysis highly desirable. Objective To update the clinical guidelines for nutrition therapy in relation to the European Association for the Study of Diabetes (EASD), a systematic review and meta-analysis of prospective studies was conducted using the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) system to summarize the evidence of the association between total nuts, specific types of nuts, and the incidence of, and mortality from, CVD outcomes. Data sources Relevant articles were identified by searching the PubMed and Cochrane databases. Data extraction Two independent researchers screened the articles to identify those that met the inclusion criteria. Data analysis The inverse variance method with fixed-effect or random-effects models was used to pool data across studies (expressed as risk ratio [RR] and 95% confidence interval [CI]). Heterogeneity was tested and quantified using the Cochrane Q test and I2-statistic, respectively. The GRADE system was used to assess the quality of the evidence. Results Nineteen studies were included in the analyses. The results revealed an inverse association between total nut consumption (comparing highest vs lowest categories) and CVD incidence (RR, 0.85; 95%CI, 0.800.91; I2, 0%), CVD mortality (RR, 0.77; 95%CI, 0.72–0.82; I2, 3%), coronary heart disease (CHD) incidence (RR, 0.82; 95%CI, 0.69–0.96; I2, 74%), CHD mortality (RR, 0.76; 95%CI, 0.67–0.86; I2, 46%), stroke mortality (RR, 0.83; 95%CI, 0.75–0.93; I2, 0%), and atrial fibrillation (RR, 0.85; 95%CI, 0.73–0.99; I2, 0%). No association was observed with stroke incidence and heart failure. The certainty of the evidence ranged from moderate to very low. Conclusions This systematic review and meta-analysis revealed a beneficial role of nut consumption in reducing the incidence of, and mortality from, different CVD outcomes.

scholarly journals Circulating and dietary magnesium and risk of cardiovascular disease: a systematic review and meta-analysis of prospective studies

2013 ◽  
Vol 98 (1) ◽  
pp. 160-173 ◽  
Author(s):  
Liana C Del Gobbo ◽  
Fumiaki Imamura ◽  
Jason HY Wu ◽  
Marcia C de Oliveira Otto ◽  
Stephanie E Chiuve ◽  
...  
Keyword(s):  
Systematic Review ◽  
Cardiovascular Disease ◽  
Prospective Studies ◽  
Meta Analysis ◽  
Dietary Magnesium

scholarly journals Biomarkers of Vascular Injury and Type 2 Diabetes: A Prospective Study, Systematic Review and Meta-Analysis

2019 ◽  
Vol 8 (12) ◽  
pp. 2075 ◽  
Author(s):  
Laura Pletsch-Borba ◽  
Cora Watzinger ◽  
Renée Turzanski Fortner ◽  
Verena Katzke ◽  
Lukas Schwingshackl ◽  
...  
Keyword(s):  
Systematic Review ◽  
Type 2 Diabetes ◽  
Vascular Injury ◽  
Prospective Studies ◽  
Meta Analysis ◽  
Positive Association ◽  
Intercellular Adhesion Molecule ◽  
Inverse Association ◽  
A Prospective Study

Data on biomarkers of vascular injury and type 2 diabetes (T2D) risk from prospective studies are lacking. We evaluated seven biomarkers of vascular injury in relation to T2D. Additionally, a meta-analysis was performed. From the EPIC–Heidelberg cohort, 2224 participants were followed-up from baseline for 16 (median) years. E-Selectin, P-Selectin, intercellular adhesion molecule 3 (ICAM3), thrombomodulin, thrombopoietin, glycoprotein IIb/IIIa and fibrinogen levels were measured in baseline blood samples. The systematic review and meta-analysis included prospective studies identified through MEDLINE and Web of Science that investigated the association between mentioned biomarkers and T2D. The study population included 55% women, median age was 50 years, and 163 developed T2D. ICAM3 was associated with lower T2D risk (fully adjusted HRhighest vs. lowest tertile 0.62 (95% CI: 0.43, 0.91)), but no other studies on ICAM3 were identified. Overall, fifteen studies were included in the systematic review and meta-analysis (6,171 cases). E-Selectin was associated with higher T2D risk HRper SD: 1.34 (95% CI: 1.16, 1.54; I2 = 63%, n = 9 studies), while thrombomodulin was associated with lower risk HRper SD: 0.82 (95% CI: 0.71, 0.95; I2 = 0%, n = 2 studies). In the EPIC–Heidelberg, ICAM3 was associated with lower T2D risk. The meta-analysis showed a consistent positive association between E-Selectin and T2D. It was also suggestive of an inverse association between thrombomodulin and T2D, although further studies are needed to corroborate this finding.

scholarly journals 100% Fruit juice intake and cardiovascular risk: a systematic review and meta-analysis of prospective and randomised controlled studies

2020 ◽  
Author(s):  
Lanfranco D’Elia ◽  
◽  
Monica Dinu ◽  
Francesco Sofi ◽  
Massimo Volpe ◽  
...  
Keyword(s):  
Blood Pressure ◽  
Cardiovascular Risk ◽  
Dose Response ◽  
Prospective Studies ◽  
Fruit Juice ◽  
Meta Analysis ◽  
Inverse Association ◽  
Non Linear ◽  
Randomised Controlled ◽  
The Relationship

Abstract Purpose The relationship between 100% fruit juice (100%FJ) consumption and cardiovascular risk is object of debate: indeed, recently published investigations provided new but discrepant evidence on this important question and International dietary guidelines are not in agreement on recommendations about fruit juice consumption. Therefore, we performed a meta-analysis of the prospective studies and the randomised controlled trials (RCTs) that explored the relationship between 100%FJ intake, cardiovascular risk profile and risk of cardiovascular events. Methods We performed a systematic search of publications up to August 2019. Summary relative risks and exploration of linearity of the association were estimated for prospective studies and summary mean differences (MDs) calculated for RCTs. Results A total of 21 prospective studies and 35 RCTs met the inclusion criteria. Dose–response analysis detected a significant inverse association between low-moderate 100%FJ consumption and risk of stroke (up to 200 ml/day) or total CV events (up to 170 ml/day) compared with no consumption, with a non-linear relationship (p for non-linearity < 0.05). No significant association was found for coronary heart disease and diabetes risk. In RCTs, a favorable and significant effect of 100%FJ intake was detected on blood pressure (systolic, MD: − 3.14 mmHg; diastolic, MD: − 1.68 mmHg), arterial compliance (carotid-femoral pulse wave velocity, − 0.38 m/s) and endothelial function (flow-mediated dilation, 2.10%). Neutral effects were found on body weight, blood lipids and glucose metabolism. Conclusions The results of these analyses indicate that 100%FJ consumption is not associated with higher CV risk. A non-linear inverse dose–response relationship occurs between 100%FJ consumption and CV disease, in particular for risk of stroke, probably mediated by the decrease in blood pressure. Trial registration PROSPERO registration number (CRD42019135577).

Endogenous oestradiol and cardiovascular disease in healthy men: a systematic review and meta-analysis of prospective studies

Heart ◽  
2012 ◽  
Vol 98 (20) ◽  
pp. 1478-1482 ◽  
Author(s):  
Guy Vandenplas ◽  
Dirk De Bacquer ◽  
Patrick Calders ◽  
Tom Fiers ◽  
Jean-Marc Kaufman ◽  
...  
Keyword(s):  
Systematic Review ◽  
Cardiovascular Disease ◽  
Prospective Studies ◽  
Meta Analysis ◽  
Healthy Men

scholarly journals Cholesterol Efflux Capacity and Its Association With Adverse Cardiovascular Events: A Systematic Review and Meta-Analysis

2021 ◽  
Vol 8 ◽  
Author(s):  
Jane J. Lee ◽  
Gerald Chi ◽  
Clara Fitzgerald ◽  
Syed Hassan A. Kazmi ◽  
Arzu Kalayci ◽  
...  
Keyword(s):  
Systematic Review ◽  
Cardiovascular Disease ◽  
Lower Risk ◽  
Cardiovascular Events ◽  
Cholesterol Efflux ◽  
Meta Analysis ◽  
Cardiovascular Outcomes ◽  
Protective Mechanism ◽  
Atherosclerotic Cardiovascular Disease ◽  
Cholesterol Efflux Capacity

Background: Serum high-density lipoprotein cholesterol (HDL-C) levels are inversely associated with cardiovascular disease events. Yet, emerging evidence suggests that it is the functional properties of HDL, in particular, reverse cholesterol transport, which is a key protective mechanism mediating cholesterol removal from macrophage cells and reducing plaque lipid content. Cholesterol efflux capacity (CEC) measures the capacity of HDL to perform this function. A systematic review and meta-analysis were conducted to explore the association of CEC and adverse cardiovascular events.Methods: A comprehensive literature review of Embase, PubMed, and Web of Science Core Collection from inception to September 2019 was performed for all studies that examined the association between CEC and cardiovascular outcomes. The primary outcome was adverse cardiovascular events, which were inclusive of atherosclerotic cardiovascular disease (ASCVD) or mortality.Results: A total of 20 trials were included. Compared with low CEC levels, high CEC levels were associated with a 37% lower risk of adverse cardiovascular events (crude RR = 0.63; 95% CI, 0.52–0.76; P &lt; 0.00001). Every SD increase of CEC was associated with a 20% lower risk of adverse cardiovascular events (HR = 0.80; 95% CI, 0.66–0.97; P = 0.02). The association remained significant after adjusting for cardiovascular risk factors, medications, and HDL-C levels (HR = 0.76; 95% CI, 0.63–0.91; P = 0.004). A significant CEC-endpoint relationship was observed (P = 0.024) such that for every 0.1 unit increase in CEC, there was a 5% reduced risk for adverse cardiovascular events (RR = 0.95; 95% CI, 0.91–0.99).Conclusions: Higher CEC is associated with lower adverse cardiovascular outcomes. These findings warrant further research on whether CEC is merely a biomarker or a mechanism that could be targeted as a pharmacologic intervention for improving clinical outcomes.PROSPERO Registration Number: CRD42020146681; https://www.crd.york.ac.uk/prospero/.

Sign in / Sign up

Export Citation Format

Share Document